Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense

Release: Oct 28, 2025

Close: Nov 21, 2025

Handheld chemical analyzer capable of rapid analytical measurement and non-destructive analysis spectrometry

Release: Oct 28, 2025

Close: Dec 22, 2025

Innovation in biologics manufacturing: Biologics (e.g., antibody) compatible cell free production capability that can support pre-clinical testing and potentially produce 5-10k dose lots of GMP drug substance. Innovations in biologics manufacturing process control (e.g., digital twins). Technologies to reduce biologics drug substance/product release time and/or enable real-time release.

Release: Oct 28, 2025

Close: Dec 19, 2025

For end-to-end untargeted genomic sequencing workflows appropriate for military use. To survey current industry capabilities in the engineering, testing, and manufacturing of solutions capable of the following: Genomic Sequencing Workflows: End-to-end, untargeted genomic sequencing workflows appropriate for military users with varying levels of technical expertise. Automation of process steps is highly desirable. Workflows must accommodate both environmental and clinical sample matrices. Field-Deployable Bioinformatics Tools: Bioinformatics tools optimized for field use, capable of detecting indicators of genetic engineering and identifying potential biological threats regardless of taxonomic classification. Test & Evaluation (T&E) Infrastructure: Technologies and infrastructure necessary for government-led T&E of untargeted sequencing approaches. Protein Toxin Sequencing: Capabilities for protein toxin sequencing, including both mobile laboratory-based systems and field-deployable platforms.